K
Kelly A. Gebo
Researcher at Johns Hopkins University
Publications - 217
Citations - 13943
Kelly A. Gebo is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 58, co-authored 180 publications receiving 12271 citations. Previous affiliations of Kelly A. Gebo include Johns Hopkins University School of Medicine & Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.
Hasina Samji,Angela Cescon,Robert S. Hogg,Robert S. Hogg,Sharada P. Modur,Keri N. Althoff,Kate Buchacz,Ann N. Burchell,Mardge H. Cohen,Kelly A. Gebo,M. John Gill,Amy C. Justice,Gregory D. Kirk,Marina B. Klein,P. Todd Korthuis,Jeffrey N. Martin,Sonia Napravnik,Sean B. Rourke,Timothy R. Sterling,Michael J. Silverberg,Stephen G. Deeks,Lisa P. Jacobson,Ronald J. Bosch,Mari M. Kitahata,James J. Goedert,Richard D. Moore,Stephen J. Gange +26 more
TL;DR: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population.
Journal ArticleDOI
Effect of early versus deferred antiretroviral therapy for HIV on survival.
Mari M. Kitahata,Stephen J. Gange,Alison G. Abraham,Barry Merriman,Michael S. Saag,Amy C. Justice,Robert S. Hogg,Steven G. Deeks,Joseph J. Eron,John T. Brooks,Sean B. Rourke,M. John Gill,Ronald J. Bosch,Jeffrey N. Martin,Marina B. Klein,Lisa P. Jacobson,Benigno Rodriguez,Timothy R. Sterling,Gregory D. Kirk,Sonia Napravnik,Anita Rachlis,Liviana Calzavara,Michael A. Horberg,Michael J. Silverberg,Kelly A. Gebo,James J. Goedert,Constance A. Benson,Ann C. Collier,Stephen E. Van Rompaey,Heidi M. Crane,Rosemary G. McKaig,Bryan Lau,Aimee M. Freeman,Richard D. Moore +33 more
TL;DR: The early initiation of antiretroviral therapy before the CD4+ count fell below two prespecified thresholds significantly improved survival, as compared with deferred therapy.
Journal ArticleDOI
Workshop on HIV Infection and Aging: What Is Known and Future Research Directions
Rita B. Effros,Courtney V. Fletcher,Kelly A. Gebo,Jeffrey B. Halter,William R. Hazzard,Frances Mc Farland Horne,Robin Huebner,Edward N. Janoff,Amy C. Justice,Daniel R. Kuritzkes,Susan G. Nayfield,Susan Plaeger,Kenneth E. Schmader,John R. Ashworth,Christine Campanelli,Charles P. Clayton,Beth Rada,Nancy Woolard,Kevin P. High +18 more
TL;DR: Researchers in infectious diseases, geriatrics, immunology, and gerontology met to review what is known about HIV infection and aging, to identify research gaps, and to suggest high priority topics for future research.
Journal ArticleDOI
HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group
Kevin P. High,Mark Brennan-Ing,David B. Clifford,Mardge H. Cohen,Judith S. Currier,Steven G. Deeks,Sherry Deren,Rita B. Effros,Kelly A. Gebo,Jörg J. Goronzy,Amy C. Justice,Alan L. Landay,Jules Levin,Paolo G. Miotti,Robert J. Munk,Heidi Nass,Charles R. Rinaldo,Michael G. Shlipak,Russell P. Tracy,Victor Valcour,David E. Vance,Jeremy D. Walston,Paul A. Volberding +22 more
TL;DR: Critical resources are needed to enact this research agenda and include expanded review panel expertise in aging, functional measures, and multimorbidity, and facilitated use and continued funding to allow long-term follow-up of cohorts aging with HIV.
Journal ArticleDOI
Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America
Michael J. Silverberg,Bryan Lau,Amy C. Justice,Amy C. Justice,Eric A. Engels,M. John Gill,James J. Goedert,Gregory D. Kirk,Gypsyamber D'Souza,Ronald J. Bosch,John T. Brooks,Sonia Napravnik,Nancy A. Hessol,Lisa P. Jacobson,Mari M. Kitahata,Marina B. Klein,Richard D. Moore,Benigno Rodriguez,Sean B. Rourke,Michael S. Saag,Timothy R. Sterling,Kelly A. Gebo,Natasha Press,Jeffrey N. Martin,Robert Dubrow +24 more
TL;DR: Anal cancer rates were substantially higher for HIV-infected MSM, other men, and women compared with HIV-uninfected individuals, suggesting a need for universal prevention efforts.